| Cory Eddington, MS, LMFT | |
|
978 Wildwood Dr, Brigham City, UT 84302-3038 | |
| (435) 723-5319 | |
| Not Available |
| Full Name | Cory Eddington |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 978 Wildwood Dr, Brigham City, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588980635 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 5079994-3902 (Utah) | Primary |
| 253J00000X | Foster Care Agency | 5079994-3902 (Utah) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Cory Eddington, MS, LMFT 978 Wildwood Dr, Brigham City, UT 84302-3038 Ph: (435) 723-5319 | Cory Eddington, MS, LMFT 978 Wildwood Dr, Brigham City, UT 84302-3038 Ph: (435) 723-5319 |
News Archive
According to a new study teenage pregnancy and motherhood is contagious within families. Scientists have discovered that the sister of a teenage mother is twice as likely to follow in her footsteps as a girl with no family experience of early motherhood.
Any expectant mother will tell you that she wants her baby's organs to develop properly in the womb. What she may not realize, however, is that a child's internal organs continue to develop for months and years after birth. This critical period is full of cellular changes that transform the organization and function of most tissues. But the exact mechanisms underlying postnatal organ maturation are still a mystery.
Low doses of an inexpensive, FDA-approved hypertension medication may improve the results of nanotherapeutic approaches to cancer treatment. In a report in the early edition of Proceedings of the National Academy of Sciences, Massachusetts General Hospital (MGH) investigators describe experiments showing that the generic drug losartan, by modifying the network of collagen fibers that characterizes most solid tumors, improved the effectiveness of two nanotherapeutics against several types of cancer.
Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the publication of a case study report based on successful treatment of Progressive Multifocal Leukoencephalopathy (PML) with combination therapy consisting of two investigational agents, Cytheris' recombinant human interleukin-7 (CYT107) and CMX001, an investigational, oral broad-spectrum antiviral drug (Chimerix, Research Triangle Park, NC) in the Journal of Antimicrobial Chemotherapy.
› Verified 9 days ago
Cindy Mcintire, PHD, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 60 S Main St Ste 100, Brigham City, UT 84302 Phone: 435-230-1849 | |
Joshua Wade Stewart, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 862 South Main Street Ste 4, Brigham City, UT 84302 Phone: 435-723-1799 | |
Sheri Allen, LAMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 862 S Main St Ste 4, Brigham City, UT 84302 Phone: 435-723-1799 | |
Chelsea Petersen, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 862 South Main Street, Suite #4, Brigham City, UT 84302 Phone: 435-723-1799 |